Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2018.02.012
Abstract: Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare disease, and up to 70% of the patients have a genetic mutation in the encoding components of complement activation or anti-complement factor H autoantibodies. The risk of… read more here.
Keywords: eculizumab; eculizumab treatment; hybrid gene; complement factor ... See more keywords
Crossâkingdom transcriptomic trends in the evolution of hybrid gene expression
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Evolutionary Biology"
DOI: 10.1111/jeb.14059
Abstract: Hybridization is a route to speciation that occurs widely across the eukaryote tree of life. The success of allopolyploids (hybrid species with increased ploidy) and homoploid hybrids (with unchanged ploidy) is well documented. However, their… read more here.
Keywords: hybrid gene; expression; kingdom; evolution hybrid ... See more keywords